English | 简体中文 | 繁體中文 | 한국어
Share:
Lubrizol Introduces Solsperse 74000 Hyperdispersant - Expands its Rad-Cure Dispersant Additive Portfolio for Printing Inks and Coatings
Lubrizol Introduces Solsperse 74000 Hyperdispersant - Expands its Rad-Cure Dispersant Additive Portfolio for Printing Inks and Coatings

  

CLEVELAND, March 15, 2017 - The Lubrizol Corporation introduces Solsperse(TM) 74000, a 100% solids wetting and dispersing agent for UV cured ink systems. Solsperse 74000 is a 100% active polymeric dispersant designed to improve operational efficiencies for both ink manufacturers and printers. Pigment concentrates and millbases made using Solsperse 74000 can achieve higher color strength at lower pigment loading, enabling higher print strength in final inks without compromising gloss, rheology or stability. These improvements are achieved across a wide range of pigments - both standard process and spot colors.

Solsperse 74000 is TSCA, DSL, REACh, Swiss Ordinance and Nestle compliant. It is APE-free1 and has no California Prop65 reportable content.

Contact Lubrizol to learn more about our full range of Solsperse high performance wetting and dispersing agents for UV cured inks and coatings.

About Lubrizol Performance Coatings

Lubrizol is a market-driven innovator of specialty chemicals that solve today's challenges in the paints and coatings, printing and packaging, paper and textiles, plastics and composites, and digital print markets. More than just a supplier, we are a partner with extensive experience in surface protection, dispersion, adhesion, and barrier properties that enables us to enhance the performance, simplicity, and eco-considerate benefits of our customers' products. With a commitment to collaboration, applied science, and demonstrated value, our team of experts is dedicated to exceeding customer expectations for both the simplest and toughest requirements. Count on Lubrizol to make the difference.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions. Our products for the oilfield market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.

Media Contact

Mike Heil

+1 (216) 447-5176

mike.heil@lubrizol.com

 

Website: https://www.lubrizol.com/coatings

 

1 APE not intentionally contained in the composition or used in manufacture of Solsperse(TM) 74000.

 





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire

Copyright © Thomson Reuters 2017. All rights reserved.
 Subscribe RSS Feed  
Press Releases
Nordic American Tankers Limited (NYSE:NAT) - Renewal and Filing of Shelf Registration Statement  
June 23, 2017 18:58 ET
NEJM publishes full analysis of Rydapt® (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)  
June 23, 2017 18:00 ET
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial  
June 23, 2017 16:45 ET
Novo Nordisk A/S: CHMP adopts positive opinion for EU label update of Victoza® based on the LEADER trial  
June 23, 2017 13:40 ET
Medtronic Announces 7 Percent Increase in Cash Dividend  
June 23, 2017 12:45 ET
Sequa Petroleum N.V. Funding Update  
June 21, 2017 00:03 ET
AIR Worldwide Releases Updated Earthquake Model for the United States  
June 19, 2017 18:13 ET
Schrader Cellars Entrusts Constellation Brands with Highly-Coveted, Critically-Acclaimed Wine Portfolio  
June 17, 2017 04:33 ET
Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair  
June 16, 2017 16:03 ET
NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop  
June 16, 2017 03:53 ET
More News >>
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: